Senior insider sale
President & CEO at NEKTAR THERAPEUTICS — senior position signals high conviction
$917.2K
22.20K shares
What this filing means
ROBIN HOWARD W plans to sell 22.20K shares of NEKTAR THERAPEUTICS valued at approximately $917.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/25/2025ACC: 0001959173-25-007276
DirectorOfficer· President & CEO
Since Aug 2018
22.20K
Shares to sell
$917.2K
Approx. market value
2.21K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/21/2025
2.21KTotal acquired2.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2025 | Restricted Stock Vesting Compensation | 2.21K | — |
| Total | 2.21K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
6.67K
Market value
$311.2K
9/9/2025
—Completed
Units to sell
6.67K
Market value
$256.8K
9/5/2025
—Completed
Units to sell
5.17K
Market value
$174.1K
9/4/2025
—Completed
Units to sell
1.50K
Market value
$45.2K
9/2/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.21K
Market value
$129.8K
11/25/2025
Total
Units
22.20K
Value
$917.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/9/2025 | 6.67K | $311.2K | — | Completed |
9/5/2025 | 6.67K | $256.8K | — | Completed |
9/4/2025 | 5.17K | $174.1K | — | Completed |
9/2/2025 | 1.50K | $45.2K | — | Completed |
| Planned — Approximate Date | ||||
11/25/2025 | 2.21K | $129.8K | NASDAQ | Planned |
| Total | 22.20K | $917.2K | ||